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An Effectiveness Hierarchy of Prevention Strategies: 
neglected paradigm or self-evident truth?  
 
 
Abstract 
   
Non-communicable disease prevention strategies usually target the four major risk factors of 
poor diet, tobacco, alcohol and physical inactivity. Yet, the most effective approaches remain 
disputed. 
However, increasing evidence supports the concept of an effectiveness hierarchy. Thus, 
“downstream” preventive activities targeting individuals (such as 1:1 personal advice, health 
education, “nudge” or primary prevention medications) consistently achieve a smaller 
population health impact than interventions aimed further “upstream” (for instance, smoke-free 
legislation, alcohol minimum pricing or regulations eliminating dietary trans-fats). These 
comprehensive, policy-based interventions reach all parts of the population and do not depend 
on a sustained “agentic” individual response. They thus tend to be more effective, more rapid, 
more equitable and also cost-saving. 
This effectiveness hierarchy is self-evident to many professionals working in public health. 
Previously neglected in the wider world, this effectiveness hierarchy now needs to be 
acknowledged by policy makers.                        
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An Effectiveness Hierarchy of Prevention Strategies:  
neglected paradigm or self-evident truth?   
 
 
Background 
 
This Perspective briefly summarises the growing evidence for a public health “effectiveness 
hierarchy”, and examines the policy implications for future preventive health strategies. 
           
The global burden of disease and disability is now mainly caused by non-communicable diseases 
(NCDs), notably heart disease, stroke, dementia, diabetes, and cancer. 1,2,  
NCD  prevention strategies are now prioritising four major risk factors: tobacco, poor diet, physical 
inactivity and alcohol.1,2,3  However, there is debate about the most effective approaches to 
prevention. Many countries have prioritised “downstream” approaches targeting individuals (such 
as screening to detect high risk patients, personal advice, primary prevention medications and 
“nudge”).3   These highly visible strategies are politically less challenging than “upstream” 
population-wide policy interventions (such as legislation, regulation, taxation or subsidies.1,2,3)   
However, the growing effectiveness evidence clearly points “upstream”.4  
 
(The apocryphal story illustrating the “upstream /downstream” metaphor is summarised in Box 1) 
      
Effectiveness Hierarchy: Neglected paradigm or self-evident truth?    
Most public health practitioners intuitively accept an effectiveness hierarchy as an obvious, self-
evident truth.5,6,7,8   Thus Frieden proposed a five tier “Health Impact Pyramid” in 2010. 9   This 
explicitly suggests that “upstream” interventions addressing socioeconomic determinants of health 
have the greatest potential population impact, and counselling and health education the least.9  
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Some enlightened clinicians have also highlighted the potentially large role of policies to prevent 
cardiovascular disease8,10  or cancer,11  and advocated using “the longest lever possible”.12 
 
However, in the wider world, most politicians and policy makers, pundits and ordinary people 
appear unaware or indifferent to this effectiveness hierarchy. They thus risk over-looking the best 
strategies for maximising the future health of their families and friends.4, 7  
 
We therefore now propose to briefly review the evidence for this effectiveness hierarchy. 
 
Evidence supporting the effectiveness hierarchy 
The evidence supporting a hierarchy of effectiveness now appears relatively extensive for all four 
of the major NCD risk factors: tobacco, diet, physical inactivity and alcohol.1,2   This evidence is  
briefly summarised below. 
           
Tobacco control 
Systematic reviews of tobacco control strategies consistently suggest that larger scale, 
comprehensive population-based approaches are more effective than individual approaches or local 
community strategies.13,14,15   The relative power of these different tobacco control interventions has 
been usefully summarised and quantified by a variety of scales including the US Tobacco Control 
Index and the European Tobacco Control Scale (TCS).16     The TCS illustrates a clear effectiveness 
hierarchy for tobacco control interventions. From a total of 100 points, 30 points are allocated to 
tobacco price, 22 points to comprehensive smokefree legislation (but only 10 points if limited to 
workplaces), 10 points for health warnings on cigarette packs, 6 points for nationwide cessation 
services for individuals and only 2 points for individual patients accessing telephone quitline 
advice16  (Figure 1).    
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Poor Diet  
A similar effectiveness hierarchy is becoming apparent in diverse interventions to improve diet.  
Our BMJ Analysis summarised the growing evidence for reducing dietary salt consumption in 
populations.17   A gradient was clearly apparent. Advice to individuals or social marketing was 
generally weak. The UK programme of sustained pressure for industry reformulation reinforced by 
media messaging was more powerful. Furthermore, comprehensive “upstream” strategies including 
regulation and marketing control (as in Finland and Japan) have been yet more powerful, achieving 
even greater reductions in daily salt consumption.17,18 (Figure 2) 
 
Similar hierarchies of effectiveness are apparent for interventions to reduce the dietary intake of 
industrial transfats, saturated fats and sugars, and also for interventions to increase the consumption 
of fresh fruit and vegetables. For instance, the biggest reductions in industrial transfat intake have 
been seen in Denmark (and soon perhaps in the USA), as the consequence of progressive and 
comprehensive policy interventions culminating in legislation.19,20 (Figure 3)   
 
Likewise, the largest country-wide reductions in saturated fat intake were achieved in Finland 
(reflecting comprehensive and sustained strategies to progressively reduce the production and 
consumption of animal and dairy fats), and in Mauritius (following a regulation banning palm oil 
imports).  Mean blood cholesterol levels subsequently fell dramatically, by 1.0 mmol/l and by 
0.8mmol/l respectively.21,22   
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Physical activity /inactivity 
 
Recent NICE reviews have summarised the growing evidence demonstrating a similar 
effectiveness hierarchy in individuals and in populations (Figure 4).  First prize goes to Cuba’s 
37% increase in physically active adults because of active travel, this being a rapid and unintended 
consequence of the major economic crisis commencing in 1989. 23  As GDP plummeted by 80% 
and fuel became scarce, the government needed to dramatically reduce private transport, promote 
public transport and also distribute a million bicycles.23   
Between 1972 and 2002, Finland implemented comprehensive national policies promoting 
walking, cycling and leisure activities. These policies substantially increased the proportion of 
physically active adults, by approximately 27% in women and by some 11% in men.24   In contrast,  
more limited transport and exercise policies further “downstream”, typically achieve smaller 
increases in physical activity, such as media campaigns, or time-limited active travel schemes 
promoting walking and cycling. In general, least has been achieved by targeting individuals for 
advice, information leaflets or exercise prescription.25,26  Furthermore, those modest benefits 
typically then diminish over time.26,27 (Figure 4) 
 
Alcohol control and cost-effectiveness 
Anderson and colleagues recently reviewed the growing evidence for reducing alcohol 
consumption in populations.28  This provided considerable additional support for a hierarchy of 
effectiveness and, crucially, also of cost-effectiveness.  Thus, brief interventions advising 
individuals cost approximately $2,700 per disability adjusted life year (DALY) saved. Interventions 
targeted further “upstream” become increasingly cost-effective, with a 50% excise tax increase 
costing much less, only $330 per DALY saved.28    
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Wider cost-effectiveness: an emerging hierarchy of interventions  
Health economists with NICE have identified increasing evidence of a similar hierarchy in the 
effectiveness and cost-effectiveness of diverse preventive interventions.  Most are now easily 
compared using the standard NICE metric: Cost per QALY. Owen and colleagues recently 
reviewed the cost-effectiveness estimates for some 200 public health interventions, most being 
relatively “downstream”.29  Thus, preventive interventions in individuals requiring statin 
medication often cost many thousands of pounds per QALY, while individual advice on behaviour 
changes, (for instance, exercise on prescription or mass media campaigns promoting healthy 
eating) usually only cost a few hundred pounds per QALY.29    
 
In contrast, “upstream” population-wide policy interventions are generally cost-saving, such as 
regulations to control tobacco or alcohol, or to reduce dietary salt or transfats; likewise subsidies to 
promote fresh fruit.30  Reassuringly similar results come from economic analyses in the UK, USA 
and Australia.31,32   The systematic review by Masters et al likewise recently observed an 
effectiveness hierarchy in over 50 diverse public health interventions.31  Interventions implemented 
locally typically gained a return on investment averaging £4 for every pound spent. “Upstream” 
nation-wide public health interventions typically demonstrated even larger benefits with a median 
return on investment of £27 for each pound invested.31   
Some interventions may even be cost-positive, ie revenue raising. Taxes on soda, and tobacco, for 
example, could actually serve to fund targeted interventions for those individuals in most need, and 
thus potentially improve health equity. 
 
Secondary benefits of prevention 
Many of the same interventions designed to prevent unhealthy behaviours can also serve to “treat” 
those who partake in behaviours which undermine their health. Taxes may prevention initiation of 
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cigarettes, but also may increase/improve quit attempts for price sensitive smokers. Likewise, 
banning the sale of tobacco products in pharmacies also decreases overall tobacco retailer density, 
thus discouraging smoking in adolescents and potentially decreasing relapse in smokers trying to 
quit.33,34  Furthermore, evidence to support this effectiveness hierarchy paradigm is also steadily 
emerging in other arenas including climate change, road safety, crime prevention and social policy.4 
(Box 2)    
 
Discussion 
Main findings of this study 
Increasing evidence supports the concept of an effectiveness hierarchy. Thus, “downstream” 
preventive activities targeting individuals (such as 1:1 personal advice, health education, “nudge” or 
primary prevention medications) consistently achieve a smaller health impact than interventions 
aimed further “upstream” (for instance, smoke-free legislation, alcohol minimum pricing or 
regulations eliminating dietary trans-fats). These comprehensive, policy-based interventions reach all 
parts of the population and do not depend on a sustained “agentic” individual response. They thus 
tend to be more effective, more equitable and also cost-saving. 
 
 
The proposed concept of an effectiveness hierarchy raises several important issues.  These include 
the underlying theoretical and ethical frameworks, equity and durability. Also crucial are the 
challenges of overcoming vested interests, wider political feasibility and operationalizing the policy 
evidence into interventions which are then effectively implemented. 
 
What is already known on this topic 
Geoffrey Rose famously demonstrated the simple mathematical principle: that a small 
improvement in the whole population (for instance dietary salt reduction to modestly lower average 
blood pressure) consistently generates larger net benefits than more intensive interventions just 
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targeting those fewer individuals at higher risk (for instance using medications for hypertension).35 
(Individual approaches typically have higher delta, but on far fewer people and with a higher per-
person expense).  
Dahlgren and Whitehead’s “layers of influence” rainbow model then helped to better conceptualise 
the “upstream” political, economic, cultural and environmental influencing factors through to 
“downstream” factors acting directly on communities and individuals.36 
More recently, McLaren and colleagues have usefully observed that all preventive interventions sit 
on a ”structural/agentic continuum”: starting from fiscal or legislative actions which change the 
environment (“structural” interventions) through to information leaflets and advice which are 
completely “agentic”, being totally dependent on an individual’s active response.37 
The latter point being recently emphasised by Adams et al.38 
The Nuffield Bioethics review suggested that public health interventions should be proportional to 
the hazard.37  Their useful Ladder of Interventions specified actions escalating from “doing 
nothing” (for a minimal risk), through progressive restrictions of an individual’s freedom of choice 
and culminating in the “elimination of choice” (for instance Danish regulations to eradicate 
industrial transfats from food).19     
 
Equity effects 
Individual preventive approaches depend mainly on agency-a person’s active response.35,36   Such 
interventions therefore tend to favour affluent and educated groups, hence potentially increasing 
inequalities.35,36  Conversely, ”structural” population-wide approaches which make the 
environment healthier generally benefit all individuals.35,36  They may thus sometimes narrow the 
inequalities gap.36, 37, 38,39,40    
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Durability and sustainability issues  
Interventions attempting behaviour change in individuals typically diminish over time: smokers 
relapse, statin adherence decreases, healthy diets drift and joggers give up.25,26,27    In contrast, the 
benefits of legislation tend to be durable (reflecting the persistent effect of an intervention, 
removing the need to reapply it), and also self-sustaining Thus, once smoking is eliminated from 
bars, or arsenic or industrial transfats eliminated from food, these health hazards are seldom 
permitted to return.   
Implementation can also become more effective over time, as illustrated by seatbelt legislation or 
smokefree environments: political resistance fades, younger cohorts inherit the new “social norms” 
and public support actually increases.4,6,38  
Some interventions are sustainable over time without the need for additional resources or upkeep. 
However, others like water fluoridation will require upkeep. However that cost is modest when 
compared with treating individuals with dental decay. 
 
Political feasibility and “upstream” approaches    
Translating evidence in to policy is neither simple nor linear.  Decision making by planners and 
policy makers is complex, reflecting many factors often considered more powerful than scientific 
evidence.44,45,46   Many hurdles exist, because the political and scientific arenas differ in terms of 
their perspectives, aims, values and practices.  Neither can legislation offer a “quick fix”.  In liberal  
democracies, successful laws generally only follow extensive public debate and growing support.18,33  
 
Happily, there is a long history of governments legislating to protect their citizens’ health. These 
regulatory successes include clean water, sanitation, air pollution, immunisation, seatbelts and 
smokefree statutes.47  Such legislative public health proposals are typically supported by the political 
centre and left; but often initially opposed by the libertarian right and commercial interests.47 
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Framing is also crucially important.  Thus, smoke free policies were framed to protect non-
smokers, where public smoking infringed on their rights. Likewise strategies framed to protect 
youth - for example, from being exposed to marketing of tobacco products or junk food.   
There are also many political levers to use, from taxes or zoning (to prevent tobacco and alcohol 
retailers from locating near schools), to licensing (alcohol retailers, tobacco retailers), or frank 
prohibition of signage or product usage. 
Applying the logic of an effectiveness hierarchy would clearly favour regulation and fiscal 
interventions at the highest levels – national, regional and global.  The Framework Convention for 
Tobacco Control (FCTC) represents a notable global success now signed by over 160 countries.43    
Similar approaches have therefore been subsequently suggested to control other harmful products 
such as alcohol, dietary transfats or sugars.48,49  The recent UN High Level Meeting on NCD 
prevention and control was thus potentially powerful, with the WHO subsequently agreeing a 
“25x25” target: a 25% reduction in NCD deaths by the year 2025.1,2         
 
However, many hurdles remain. The FCTC was only achieved in 2005, five decades after clear 
scientific evidence of tobacco harm, and only after two decades of sustained advocacy and 
activism.41  In reality, any such concerted global actions will be predictably and energetically 
opposed and obstructed by commercial vested interests.48-54    As suppliers of unhealthy commodities, 
“Big Tobacco”, “Big Alcohol” and “Big Food” companies obviously prioritise profit, not public 
health.48-56   Furthermore, these “disease promoting industries” use remarkably similar tactics intended 
to delay, dilute or demolish effective regulation.48-56   For instance, claiming that “nanny state” 
policies erode individual autonomy or  harm economic growth.47,49  
 
Similarly obstructive commercial lobbying has recently been seen at the US federal level, 
frustrating public health regulation to combat child obesity.48-50   In contrast, over 25 individual 
states and US metropolitan areas have successfully implemented  “soda taxes” on sugary drinks, 
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most recently Berkeley, San Francisco, Philadelphia, Oakland, Boulder and Chicago.54     Similarly, 
over 30 cities and states have now enacted protective legislation on smoke-free public spaces.55,56,57  
 
Similarly in Europe, public health progress has often been similarly sabotaged at the 
European Union level. For instance, the recent Tobacco Products Directive was 
systematically weakened by sustained lobbying, and the EU proposal for front-of-pack food 
labelling to effectively inform consumers was derailed by massive food industry 
opposition.55,56    Happily however, individual European member countries have been 
politically more agile, (much like leading US cities and states57,58 ). They have successfully 
achieved effective regulation and taxation to control tobacco,15,16  alcohol,51 transfats,19,20 
salt17,18 and sugar. 53,54   
The failure of “nudge” and partnership approaches 
In stark contrast to healthy policies, non-regulatory voluntary agreements and “partnerships” 
with industry have consistently proven weak or ineffective, not least by de-emphasising 
upstream issues.  For example, “responsibility deals” which depend on “nudge” and non-
specific “pledges” from industry have received increasingly devastating criticism in the UK, 
Europe and the USA.59-64 (Box 3) 
      
Limitations of this study 
 
This brief review has many limitations.  Firstly, the scientific evidence still remains relatively 
sparse,   and might be selectively quoted.  However, recently emerging results are supportive, 
notably recent systematic reviews of policies to reduce the dietary intake of salt, and trans-
fats,18,20 and the economic return on investment of  diverse public health interventions. 31  A more 
comprehensive programme of primary research and systematic reviews should therefore now 
formally test the effectiveness hierarchy paradigm in a wider range of specific areas.65   Looking 
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beyond the classical four NCD risk factors will also be important and potentially exciting (Box 
3).4  
 
Secondly, demanding the medical “gold-standard” of randomised trials is easy when 
assessing patient therapies, but seldom feasible for evaluating upstream national policy 
interventions.  Thus most policy effect sizes represent estimates based on analyses of natural 
experiments interrupted time-series or observational cohorts.66,67   Furthermore, these effect 
sizes have been quantified using a variety of outcome metrics.  This heterogeneity limits 
comparisons of effectiveness and highlights the value of promoting a standard methodology, such 
as costs per QALY or DALY.26,29   
Thirdly, needing to acknowledge the potential for unintended consequences of population 
wide interventions. Thus, if population wide policies are enduring, sustainable and wide 
reaching, they should be fully evaluated for unintended effects prior to general 
implementation. For example, the 1920s US prohibition of alcohol fuelling crime , or media 
campaigns on obesity resulting in shaming, bullying, stigma or negative mental health 
consequences. 
Fourthly, considering any policy intervention in isolation is slightly artificial.  Preventive 
interventions in the messy real world are delivered in a wider social, cultural and economic 
context which may be supportive, neutral or obstructive.  Thus, in tobacco control, 
combinations of interventions within comprehensive strategies can produce additive or even 
synergistic benefits.68  Therefore “upstream” interventions banning advertising typically 
create a more favourable environment which will then support the individual advised by their 
doctor to stop smoking.  A systems approach involving a comprehensive, multi-level, multi-
sectorial strategy may thus achieve “the maximum possible sustained public health gains”. 
6,7,8,9,18,20, 66,68,69    Furthermore, benefits which can often occur surprisingly rapidly, within 
months rather than decades.70       
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The public and policy implications of a preventive effectiveness hierarchy  
 
As the emerging evidence strengthens, so the implications become increasingly clear. 
 
1. Future strategies proposed for non-communicable disease prevention should strive 
to prioritise “upstream” approaches using regulation, taxation, subsidies and 
comprehensive approaches.   Policy makers and politicians will therefore need to 
champion these “upstream” interventions at the highest international levels (including the 
World Bank, United Nations, World Health Organisation, World Trade Organisation, 
and Codex Alimentarius).  
 
2. Interventions further “downstream” and closer to the individual generally become 
progressively weaker and more expensive.  They therefore merit greater scepticism from 
planners and policy makers.   
 
3. High income countries can fudge the choice between population-wide and 
individual approaches to prevention.  They can afford both, and might therefore 
portray these strategies as “complementary”.  However, low and middle income 
countries face limited budgets and starker choices. They cannot quite so easily dismiss 
the emerging evidence on effectiveness and cost-effectiveness summarised here.  
 
4. Opposition by commercial vested interests might be anticipated.   Because 
corporations will routinely resist any proposed public health regulation which might 
threaten their profits. However, the health of the public tends to triumph, eventually.47 
 
In conclusion, most policy makers and planners are facing growing disease burdens and 
shrinking healthcare budgets. Thus when considering future prevention strategies, they will 
increasingly need to prioritise those upstream policies which would most benefit their entire 
populations. They can no longer afford to neglect the public health effectiveness hierarchy.   
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Box 1 
 
 
 
 
 
  
  
The apocryphal story about “upstream” and “downstream” prevention 
 
While walking by the river, a philosopher came upon people drowning in the 
turbulent water.  He observed a young man pulling each drowning individual out of the 
river. The young man cried “Come and help me!”   
But instead, the philosopher walked further upstream.  Nearing the town, he 
discovered a narrow footbridge - crowded, unfenced and unsafe. Thus many people 
were falling off the bridge into the river.  
The philosopher persuaded the town authorities to fit a simple handrail to the bridge.   
After that, people no longer fell in and drowned. 
Downstream, the exhausted young man could then return home and feed his family. 
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Box 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Evidence supporting the effectiveness hierarchy paradigm 
 
Extensive evidence 
Tobacco control 
Diet interventions 
Physical activity 
Alcohol control 
 
Emerging Evidence  
Air pollution 
Breast feeding  
Clean water 
Climate change 
Crime prevention 
Drug addiction 
Fire prevention 
Gun Control 
Injury prevention 
Mental health  
Poverty 
Road safety 
Unemployment  
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Figure 1   Tobacco Control Score (TCS):  
Estimated effects of different policy options 
 
 
Figure 2   Dietary Salt Reduction:  
Estimated effects of different policy options 
 
 
Figure 3   Dietary Industrial Transfat Reduction:  
Estimated effects of different policy options 
 
 
Figure 4   Interventions Increasing Physical Activity:  
Estimated effects of different policy options 
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